导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.57% | 713/1050 |
| 近一周 | -1.25% | 168/1104 |
| 近一月 | -4.47% | 552/1102 |
| 近一季 | -1.24% | 298/1092 |
| 近半年 | -8.07% | 705/1070 |
| 近一年 | -4.37% | 646/1018 |
| 近两年 | 24.00% | 734/926 |
| 近三年 | 31.13% | 387/834 |
| 成立以来 | 433.97% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.21% 662/1070 |
-5.59% 812/1101 |
- - |
- - |
| 2025 | 15.39% 748/1065 |
6.21% 322/1014 |
-0.75% 743/1038 |
7.66% 883/1050 |
1.68% 333/1065 |
| 2024 | 29.01% 25/1011 |
10.33% 28/960 |
6.32% 71/983 |
9.24% 683/991 |
0.67% 284/1011 |
| 2023 | 5.23% 44/952 |
7.81% 176/880 |
5.80% 33/895 |
-1.71% 146/915 |
-6.14% 609/952 |
| 2022 | -17.92% 254/867 |
-16.99% 359/773 |
5.82% 470/806 |
-8.53% 165/845 |
2.15% 317/867 |
| 2021 | 27.95% 86/740 |
1.48% 98/580 |
2.18% 509/659 |
6.21% 103/704 |
16.18% 16/740 |
| 2020 | 60.26% 192/554 |
-7.38% 344/419 |
22.71% 230/466 |
21.09% 46/517 |
16.46% 179/554 |
| 2019 | 42.20% 204/410 |
21.93% 871/1149 |
2.83% 120/1231 |
3.96% 223/390 |
9.10% 186/410 |
| 2018 | -15.75% 30/349 |
- - |
- - |
- - |
-7.39% 123/1080 |
| 2017 | 36.33% 19/285 |
- - |
- - |
- - |
- - |
| 2016 | 0.83% 26/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 大成高新技术产业股票A VS. 东吴新产业精选股票A(580008) |